以色列 - 希伯来文 - Ministry of Health

bayer israel ltd - moxifloxacin - תמיסה לאינפוזיה - moxifloxacin 400 mg / 250 ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

以色列 - 希伯来文 - Ministry of Health

bioavenir ltd, israel - ciprofloxacin - תמיסה לאינפוזיה - ciprofloxacin 200 mg / 100 ml - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: treatment of acute pulmonary exacerbation of cystic fibrosis associated with p.aeroginosa infections in pediatric patients aged 5-17 years.

以色列 - 希伯来文 - Ministry of Health

sanofi - aventis israel ltd - levofloxacin as hemihydrate - תמיסה לאינפוזיה - levofloxacin as hemihydrate 5 mg/ml - levofloxacin - levofloxacin - in adults for whom intravenous therapy is considered to be appropriate, tavanic solution for infusion is indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: community- acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

以色列 - 希伯来文 - Ministry of Health

eli lilly israel ltd - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 30 mg - duloxetine - duloxetine - - cymbalta is indicated for the treatment of major depressive episodes. - cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy. - cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain. this has been established is studies in patients with chronic low back pain and chronic pain due to osteoarthritis when other therapies have failed or are contra-indicated.

以色列 - 希伯来文 - Ministry of Health

eli lilly israel ltd - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 60 mg - duloxetine - duloxetine - - cymbalta is indicated for the treatment of major depressive episodes. - cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy. - cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain. this has been established is studies in patients with chronic low back pain and chronic pain due to osteoarthritis when other therapies have failed or are contra-indicated..

以色列 - 希伯来文 - Ministry of Health

bioavenir ltd, israel - ofloxacin - תמיסה לעין - ofloxacin 3 mg / 1 ml - ofloxacin

以色列 - 希伯来文 - Ministry of Health

unipharm ltd, israel - levofloxacin as hemihydrate - טבליה - levofloxacin as hemihydrate 500 mg - levofloxacin

以色列 - 希伯来文 - Ministry of Health

fischer pharma rx ltd - ofloxacin - ofloxacin 3 mg / 1 g - ofloxacin

以色列 - 希伯来文 - Ministry of Health

teva pharmaceutical indust.ltd - moxifloxacin as hydrochloride 0.5 % - ophthalmic solution - moxifloxacin - for the treatment of bacterial conjunctivitis caused by susceptible strains or organisms.

以色列 - 希伯来文 - Ministry of Health

eliezer linevitz ltd. - marbofloxacin - תמיסה להזרקה - marbofloxacin 100 mg/ml - in cattle: treatment of respiratory infections caused by sensitive strains of pasteurella multocida, pasteurella haemolytica bovis. in sows: treatment of metritis mastitis agalactia syndrome caused by bacterial strains sensitive to marbofloxacin treatment in both species should be given only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).